Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Coronary Angiography | 120 | 2024 | 4541 | 8.570 |
Why?
|
Coronary Stenosis | 38 | 2024 | 802 | 7.330 |
Why?
|
Plaque, Atherosclerotic | 45 | 2024 | 1550 | 6.670 |
Why?
|
Coronary Artery Disease | 99 | 2024 | 6569 | 5.960 |
Why?
|
Coronary Vessels | 47 | 2024 | 3124 | 4.600 |
Why?
|
Acute Coronary Syndrome | 40 | 2024 | 2194 | 4.500 |
Why?
|
Chest Pain | 40 | 2024 | 1101 | 4.320 |
Why?
|
Tomography, X-Ray Computed | 85 | 2024 | 20776 | 2.510 |
Why?
|
Predictive Value of Tests | 71 | 2025 | 15471 | 2.140 |
Why?
|
Angina Pectoris | 8 | 2021 | 957 | 2.070 |
Why?
|
Troponin I | 8 | 2022 | 662 | 1.560 |
Why?
|
Societies, Medical | 14 | 2024 | 3968 | 1.260 |
Why?
|
Troponin | 8 | 2024 | 535 | 1.210 |
Why?
|
Fractional Flow Reserve, Myocardial | 4 | 2020 | 346 | 1.140 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 15 | 2024 | 1232 | 0.960 |
Why?
|
Exercise Test | 8 | 2020 | 2187 | 0.880 |
Why?
|
Cardiology | 10 | 2024 | 1701 | 0.880 |
Why?
|
Anniversaries and Special Events | 1 | 2024 | 97 | 0.880 |
Why?
|
Risk Assessment | 43 | 2024 | 24333 | 0.850 |
Why?
|
Heart Diseases | 9 | 2023 | 2819 | 0.800 |
Why?
|
Calcinosis | 13 | 2018 | 1479 | 0.750 |
Why?
|
Calcium | 13 | 2023 | 5792 | 0.720 |
Why?
|
Cardiovascular Diseases | 14 | 2024 | 15661 | 0.720 |
Why?
|
Atherosclerosis | 9 | 2025 | 3431 | 0.710 |
Why?
|
Tomography, Optical Coherence | 12 | 2024 | 2957 | 0.700 |
Why?
|
Tomography, Spiral Computed | 8 | 2008 | 274 | 0.700 |
Why?
|
Myocardial Infarction | 21 | 2024 | 11521 | 0.680 |
Why?
|
Prognosis | 37 | 2024 | 30046 | 0.680 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2024 | 3253 | 0.660 |
Why?
|
Humans | 219 | 2025 | 768970 | 0.590 |
Why?
|
Risk Factors | 52 | 2024 | 74976 | 0.560 |
Why?
|
Severity of Illness Index | 27 | 2024 | 15951 | 0.540 |
Why?
|
Middle Aged | 119 | 2025 | 223737 | 0.530 |
Why?
|
Primary Prevention | 2 | 2024 | 1187 | 0.510 |
Why?
|
Radiographic Image Enhancement | 9 | 2014 | 877 | 0.500 |
Why?
|
Hemodynamics | 2 | 2024 | 4199 | 0.500 |
Why?
|
Emergency Service, Hospital | 23 | 2023 | 7957 | 0.490 |
Why?
|
Coronary Disease | 8 | 2017 | 5919 | 0.490 |
Why?
|
Constriction, Pathologic | 5 | 2023 | 1104 | 0.480 |
Why?
|
Male | 132 | 2025 | 365203 | 0.460 |
Why?
|
Female | 133 | 2025 | 397515 | 0.450 |
Why?
|
Arteriosclerosis | 1 | 2018 | 1056 | 0.440 |
Why?
|
Myocardial Revascularization | 6 | 2020 | 796 | 0.430 |
Why?
|
Neoplasms | 5 | 2025 | 22389 | 0.380 |
Why?
|
Rupture, Spontaneous | 6 | 2024 | 365 | 0.380 |
Why?
|
Angiocardiography | 1 | 2010 | 149 | 0.360 |
Why?
|
Aged | 74 | 2024 | 171786 | 0.350 |
Why?
|
Cardiovascular System | 3 | 2023 | 841 | 0.340 |
Why?
|
Automation | 4 | 2017 | 589 | 0.320 |
Why?
|
Reproducibility of Results | 23 | 2024 | 20245 | 0.320 |
Why?
|
Observer Variation | 9 | 2018 | 2623 | 0.320 |
Why?
|
Echocardiography, Stress | 3 | 2021 | 139 | 0.310 |
Why?
|
Ultrasonography, Interventional | 7 | 2018 | 1524 | 0.310 |
Why?
|
Myocardial Ischemia | 2 | 2018 | 2139 | 0.300 |
Why?
|
Sensitivity and Specificity | 27 | 2021 | 14752 | 0.300 |
Why?
|
Contrast Media | 15 | 2019 | 5334 | 0.300 |
Why?
|
Prospective Studies | 38 | 2024 | 54962 | 0.290 |
Why?
|
Heart Transplantation | 4 | 2013 | 3301 | 0.290 |
Why?
|
Periodicals as Topic | 4 | 2024 | 1470 | 0.290 |
Why?
|
Diffusion of Innovation | 5 | 2024 | 732 | 0.280 |
Why?
|
Diagnostic Imaging | 4 | 2023 | 3538 | 0.280 |
Why?
|
Leg | 2 | 2023 | 1089 | 0.280 |
Why?
|
Iohexol | 2 | 2019 | 205 | 0.280 |
Why?
|
Heart Function Tests | 3 | 2020 | 317 | 0.270 |
Why?
|
Enterococcus faecium | 3 | 2005 | 101 | 0.270 |
Why?
|
Heart Ventricles | 6 | 2020 | 3840 | 0.260 |
Why?
|
Myocardial Perfusion Imaging | 3 | 2020 | 672 | 0.260 |
Why?
|
Adipose Tissue | 7 | 2024 | 3335 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 11 | 2017 | 9080 | 0.250 |
Why?
|
Cell Adhesion Molecules | 3 | 2001 | 1614 | 0.250 |
Why?
|
Triage | 6 | 2016 | 997 | 0.240 |
Why?
|
Peripheral Arterial Disease | 3 | 2022 | 1304 | 0.240 |
Why?
|
Arterial Occlusive Diseases | 2 | 2023 | 746 | 0.230 |
Why?
|
Evidence-Based Medicine | 7 | 2024 | 3709 | 0.230 |
Why?
|
Pericardium | 3 | 2020 | 679 | 0.220 |
Why?
|
Probiotics | 3 | 2005 | 383 | 0.220 |
Why?
|
Algorithms | 11 | 2020 | 14201 | 0.210 |
Why?
|
Acute Disease | 9 | 2019 | 7245 | 0.210 |
Why?
|
United States | 21 | 2024 | 73186 | 0.210 |
Why?
|
Superoxides | 4 | 2001 | 389 | 0.210 |
Why?
|
Pulmonary Veins | 2 | 2024 | 758 | 0.210 |
Why?
|
Aortic Valve | 5 | 2023 | 1969 | 0.210 |
Why?
|
Area Under Curve | 4 | 2015 | 1645 | 0.210 |
Why?
|
Cardiac-Gated Imaging Techniques | 3 | 2019 | 139 | 0.200 |
Why?
|
Retrospective Studies | 26 | 2024 | 81903 | 0.190 |
Why?
|
Coronary Circulation | 4 | 2024 | 1617 | 0.190 |
Why?
|
Telecommunications | 1 | 2021 | 79 | 0.190 |
Why?
|
Electrocardiography | 9 | 2017 | 6413 | 0.190 |
Why?
|
Inflammation | 8 | 2024 | 10868 | 0.180 |
Why?
|
Consensus | 4 | 2024 | 3214 | 0.180 |
Why?
|
Heart | 5 | 2024 | 4447 | 0.180 |
Why?
|
Journal Impact Factor | 1 | 2022 | 156 | 0.180 |
Why?
|
Phantoms, Imaging | 2 | 2006 | 2533 | 0.170 |
Why?
|
Cardiac Volume | 1 | 2021 | 197 | 0.170 |
Why?
|
Adult | 44 | 2024 | 223851 | 0.170 |
Why?
|
Curriculum | 2 | 2024 | 3782 | 0.170 |
Why?
|
Ventricular Function, Left | 3 | 2007 | 3941 | 0.170 |
Why?
|
Lipoprotein(a) | 1 | 2024 | 490 | 0.170 |
Why?
|
Microvascular Angina | 1 | 2019 | 14 | 0.160 |
Why?
|
Venous Insufficiency | 1 | 2001 | 109 | 0.160 |
Why?
|
Multivariate Analysis | 7 | 2017 | 12095 | 0.160 |
Why?
|
Biomedical Research | 3 | 2021 | 3463 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2019 | 10400 | 0.160 |
Why?
|
Aorta | 2 | 2005 | 2046 | 0.160 |
Why?
|
American Heart Association | 2 | 2022 | 1051 | 0.160 |
Why?
|
ROC Curve | 6 | 2019 | 3629 | 0.160 |
Why?
|
Echocardiography | 6 | 2019 | 5047 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 810 | 0.150 |
Why?
|
Advisory Committees | 1 | 2022 | 797 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1575 | 0.150 |
Why?
|
Cohort Studies | 14 | 2023 | 41808 | 0.150 |
Why?
|
Preventive Health Services | 1 | 2022 | 570 | 0.140 |
Why?
|
Arteries | 1 | 2022 | 1126 | 0.140 |
Why?
|
Cardiology Service, Hospital | 1 | 2019 | 242 | 0.140 |
Why?
|
Critical Pathways | 1 | 2021 | 476 | 0.140 |
Why?
|
Myocarditis | 1 | 2025 | 803 | 0.140 |
Why?
|
Cardiotoxins | 1 | 2016 | 36 | 0.140 |
Why?
|
Adjuvants, Immunologic | 2 | 2000 | 999 | 0.140 |
Why?
|
Retroperitoneal Fibrosis | 1 | 2016 | 42 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2771 | 0.130 |
Why?
|
Odds Ratio | 7 | 2021 | 9684 | 0.130 |
Why?
|
Cardiomyopathies | 2 | 2025 | 2057 | 0.130 |
Why?
|
Triiodobenzoic Acids | 5 | 2008 | 123 | 0.130 |
Why?
|
Phenotype | 4 | 2024 | 16731 | 0.130 |
Why?
|
Neutrophils | 6 | 2001 | 3785 | 0.130 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1945 | 0.120 |
Why?
|
Hospitalization | 8 | 2021 | 10847 | 0.120 |
Why?
|
Inflammation Mediators | 2 | 2001 | 1890 | 0.120 |
Why?
|
Angina, Unstable | 4 | 2021 | 893 | 0.120 |
Why?
|
Aortic Diseases | 1 | 2021 | 741 | 0.120 |
Why?
|
Prevalence | 7 | 2024 | 15879 | 0.120 |
Why?
|
Vasculitis | 1 | 2019 | 525 | 0.120 |
Why?
|
North America | 4 | 2019 | 1290 | 0.120 |
Why?
|
Aortic Valve Stenosis | 2 | 2023 | 2034 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 2 | 2008 | 308 | 0.110 |
Why?
|
Photography | 1 | 2017 | 537 | 0.110 |
Why?
|
Disease Progression | 8 | 2017 | 13674 | 0.110 |
Why?
|
Heart Valve Diseases | 2 | 2016 | 1030 | 0.110 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2023 | 1252 | 0.110 |
Why?
|
Ultrasonography | 5 | 2015 | 6002 | 0.110 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2015 | 1141 | 0.110 |
Why?
|
Multicenter Studies as Topic | 1 | 2018 | 1737 | 0.110 |
Why?
|
Time Factors | 12 | 2024 | 40261 | 0.100 |
Why?
|
Arteriovenous Fistula | 2 | 2024 | 320 | 0.100 |
Why?
|
Emergency Medical Services | 2 | 2018 | 1947 | 0.100 |
Why?
|
Feasibility Studies | 4 | 2019 | 5323 | 0.100 |
Why?
|
Aortitis | 1 | 2013 | 77 | 0.100 |
Why?
|
Mammaplasty | 1 | 2022 | 1263 | 0.100 |
Why?
|
Radiotherapy | 1 | 2019 | 1506 | 0.100 |
Why?
|
Software | 2 | 2017 | 4479 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2006 | 2276 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2022 | 3232 | 0.100 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6547 | 0.100 |
Why?
|
Health Records, Personal | 1 | 2013 | 127 | 0.100 |
Why?
|
Monitoring, Physiologic | 1 | 2019 | 1798 | 0.090 |
Why?
|
Aortic Valve Insufficiency | 2 | 2007 | 577 | 0.090 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 954 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 2149 | 0.090 |
Why?
|
Registries | 2 | 2018 | 8384 | 0.090 |
Why?
|
Ventricular Remodeling | 1 | 2018 | 1282 | 0.090 |
Why?
|
Logistic Models | 5 | 2017 | 13318 | 0.090 |
Why?
|
Outpatients | 1 | 2018 | 1603 | 0.080 |
Why?
|
Quaternary Ammonium Compounds | 1 | 1990 | 204 | 0.080 |
Why?
|
Carotid Stenosis | 1 | 2017 | 862 | 0.080 |
Why?
|
Dyspnea | 1 | 2017 | 1352 | 0.080 |
Why?
|
Women's Health | 1 | 2018 | 2081 | 0.080 |
Why?
|
Health Care Costs | 2 | 2019 | 3270 | 0.080 |
Why?
|
Artifacts | 3 | 2007 | 1942 | 0.080 |
Why?
|
Diagnosis, Differential | 7 | 2019 | 13021 | 0.080 |
Why?
|
Aorta, Thoracic | 2 | 2013 | 1112 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2597 | 0.080 |
Why?
|
Lipid Metabolism | 2 | 2013 | 1904 | 0.070 |
Why?
|
Image Enhancement | 2 | 2017 | 2898 | 0.070 |
Why?
|
Troponin T | 1 | 2013 | 787 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11886 | 0.070 |
Why?
|
Proportional Hazards Models | 3 | 2017 | 12562 | 0.070 |
Why?
|
Collateral Circulation | 1 | 2008 | 291 | 0.070 |
Why?
|
Angiography | 2 | 2023 | 1598 | 0.070 |
Why?
|
Comprehension | 1 | 2013 | 639 | 0.070 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2008 | 153 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.070 |
Why?
|
Alzheimer Disease | 3 | 2006 | 8760 | 0.070 |
Why?
|
Myocardial Reperfusion | 1 | 2008 | 339 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 8 | 2023 | 36854 | 0.070 |
Why?
|
Anatomy, Cross-Sectional | 1 | 2007 | 139 | 0.070 |
Why?
|
Documentation | 1 | 2013 | 917 | 0.070 |
Why?
|
Markov Chains | 2 | 2020 | 979 | 0.070 |
Why?
|
Drug Prescriptions | 1 | 2015 | 1673 | 0.070 |
Why?
|
Sex Factors | 5 | 2021 | 10633 | 0.060 |
Why?
|
Imaging, Three-Dimensional | 2 | 2017 | 4076 | 0.060 |
Why?
|
Survivors | 1 | 2016 | 2383 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4835 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2013 | 2734 | 0.060 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3438 | 0.060 |
Why?
|
Atrial Fibrillation | 3 | 2011 | 5176 | 0.060 |
Why?
|
Catheter Ablation | 2 | 2011 | 2780 | 0.060 |
Why?
|
Lower Extremity | 2 | 2023 | 1217 | 0.060 |
Why?
|
Cholesterol | 2 | 2023 | 2913 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2023 | 39394 | 0.060 |
Why?
|
Integrin alpha4 | 1 | 2005 | 88 | 0.060 |
Why?
|
Electric Countershock | 1 | 2008 | 534 | 0.060 |
Why?
|
Incidence | 4 | 2017 | 21547 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8894 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2013 | 2056 | 0.060 |
Why?
|
Aged, 80 and over | 11 | 2019 | 59739 | 0.060 |
Why?
|
Heart Atria | 2 | 2011 | 1361 | 0.060 |
Why?
|
Patient Discharge | 3 | 2024 | 3491 | 0.060 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2017 | 3411 | 0.060 |
Why?
|
Aspirin | 1 | 2015 | 3135 | 0.060 |
Why?
|
Immunotherapy | 1 | 2000 | 4756 | 0.060 |
Why?
|
Glucuronidase | 3 | 2001 | 205 | 0.050 |
Why?
|
Single-Blind Method | 4 | 2009 | 1586 | 0.050 |
Why?
|
Nonlinear Dynamics | 1 | 2006 | 494 | 0.050 |
Why?
|
Fibrosis | 2 | 2024 | 2080 | 0.050 |
Why?
|
Angioplasty, Balloon | 1 | 2007 | 592 | 0.050 |
Why?
|
Echocardiography, Doppler | 1 | 2007 | 898 | 0.050 |
Why?
|
Muramidase | 2 | 2001 | 163 | 0.050 |
Why?
|
Comparative Effectiveness Research | 2 | 2019 | 714 | 0.050 |
Why?
|
Neurofibrillary Tangles | 2 | 2006 | 459 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2020 | 4879 | 0.050 |
Why?
|
Epigastric Arteries | 1 | 2022 | 93 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2025 | 280 | 0.050 |
Why?
|
Heart Rate | 4 | 2007 | 4217 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2006 | 835 | 0.050 |
Why?
|
Overweight | 1 | 2013 | 2448 | 0.050 |
Why?
|
Motion | 1 | 2006 | 794 | 0.050 |
Why?
|
Peroxidase | 3 | 2001 | 610 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2003 | 527 | 0.050 |
Why?
|
Calcium-Binding Proteins | 1 | 2006 | 1083 | 0.050 |
Why?
|
Statistics, Nonparametric | 2 | 2005 | 2862 | 0.050 |
Why?
|
Adiposity | 2 | 2023 | 1895 | 0.050 |
Why?
|
Natural Language Processing | 2 | 2020 | 1203 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2024 | 396 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8749 | 0.050 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2005 | 1133 | 0.050 |
Why?
|
Calibration | 1 | 2003 | 822 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2013 | 3859 | 0.050 |
Why?
|
Pancreatic Elastase | 1 | 2001 | 125 | 0.040 |
Why?
|
Double-Blind Method | 5 | 2013 | 12467 | 0.040 |
Why?
|
California | 2 | 2019 | 1443 | 0.040 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2023 | 268 | 0.040 |
Why?
|
Postoperative Care | 1 | 2007 | 1481 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6673 | 0.040 |
Why?
|
Societies, Scientific | 1 | 2021 | 223 | 0.040 |
Why?
|
Multiple Myeloma | 1 | 2018 | 5196 | 0.040 |
Why?
|
Intermittent Claudication | 1 | 2022 | 305 | 0.040 |
Why?
|
Stroke | 1 | 2022 | 9756 | 0.040 |
Why?
|
Syndrome | 4 | 2007 | 3274 | 0.040 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2008 | 2145 | 0.040 |
Why?
|
Referral and Consultation | 1 | 2013 | 3628 | 0.040 |
Why?
|
Esophagus | 1 | 2005 | 1043 | 0.040 |
Why?
|
Lysosomes | 3 | 1994 | 940 | 0.040 |
Why?
|
Pyrazoles | 2 | 2019 | 2029 | 0.040 |
Why?
|
Cost-Benefit Analysis | 3 | 2020 | 5544 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8055 | 0.040 |
Why?
|
Linear Models | 2 | 2013 | 5891 | 0.040 |
Why?
|
Oregon | 1 | 2019 | 149 | 0.040 |
Why?
|
Boston | 4 | 2013 | 9377 | 0.040 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2001 | 361 | 0.040 |
Why?
|
Lipids | 2 | 2024 | 3345 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2025 | 13698 | 0.040 |
Why?
|
Free Radicals | 1 | 1999 | 238 | 0.040 |
Why?
|
Decision Making | 2 | 2015 | 3953 | 0.040 |
Why?
|
Lactones | 1 | 2001 | 316 | 0.040 |
Why?
|
Animals | 9 | 2019 | 169335 | 0.040 |
Why?
|
Aortography | 2 | 2013 | 422 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2022 | 682 | 0.040 |
Why?
|
Sulfones | 1 | 2001 | 448 | 0.040 |
Why?
|
Lipoproteins | 1 | 2022 | 880 | 0.040 |
Why?
|
Spain | 1 | 2019 | 485 | 0.040 |
Why?
|
Chronic Disease | 2 | 2024 | 9384 | 0.040 |
Why?
|
Radiation Dosage | 2 | 2018 | 1970 | 0.040 |
Why?
|
Anticholesteremic Agents | 1 | 2005 | 972 | 0.040 |
Why?
|
Mortality | 2 | 2019 | 2914 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 1990 | 4207 | 0.040 |
Why?
|
Physical Examination | 1 | 2023 | 1262 | 0.040 |
Why?
|
Brachial Artery | 1 | 2019 | 373 | 0.040 |
Why?
|
Antibody Formation | 2 | 2000 | 1393 | 0.040 |
Why?
|
Protein Synthesis Inhibitors | 4 | 1962 | 188 | 0.030 |
Why?
|
Lymphocytes | 1 | 2005 | 2614 | 0.030 |
Why?
|
Obesity | 2 | 2023 | 13091 | 0.030 |
Why?
|
Reference Values | 1 | 2004 | 4940 | 0.030 |
Why?
|
Blood Bactericidal Activity | 1 | 1976 | 124 | 0.030 |
Why?
|
Antioxidants | 2 | 2006 | 1673 | 0.030 |
Why?
|
Purines | 1 | 2019 | 615 | 0.030 |
Why?
|
Singapore | 1 | 2016 | 299 | 0.030 |
Why?
|
Monocytes | 1 | 2005 | 2603 | 0.030 |
Why?
|
Tetracycline | 3 | 1961 | 216 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2022 | 21188 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2003 | 6236 | 0.030 |
Why?
|
Models, Economic | 1 | 2019 | 721 | 0.030 |
Why?
|
Electrodes | 1 | 2017 | 617 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2403 | 0.030 |
Why?
|
Ischemia | 1 | 2023 | 1900 | 0.030 |
Why?
|
Phagocytosis | 2 | 2000 | 1530 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2006 | 3139 | 0.030 |
Why?
|
Sodium Dodecyl Sulfate | 1 | 1994 | 124 | 0.030 |
Why?
|
Mastectomy | 1 | 2022 | 1850 | 0.030 |
Why?
|
Cost Savings | 1 | 2019 | 915 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1560 | 0.030 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2013 | 119 | 0.030 |
Why?
|
Practice Guidelines as Topic | 4 | 2014 | 7460 | 0.030 |
Why?
|
Iopamidol | 1 | 2013 | 187 | 0.030 |
Why?
|
Patient Selection | 2 | 2017 | 4265 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 1514 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1064 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 812 | 0.030 |
Why?
|
Cell Communication | 1 | 2000 | 1660 | 0.030 |
Why?
|
Quality-Adjusted Life Years | 1 | 2019 | 1741 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.020 |
Why?
|
Minority Groups | 1 | 2019 | 1216 | 0.020 |
Why?
|
Blood Pressure | 1 | 2008 | 8544 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2021 | 2194 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1620 | 0.020 |
Why?
|
Catalase | 3 | 1976 | 215 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 1994 | 693 | 0.020 |
Why?
|
Sulfonamides | 1 | 2001 | 1981 | 0.020 |
Why?
|
Intestines | 1 | 2000 | 1911 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 752 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 836 | 0.020 |
Why?
|
Age Distribution | 2 | 2008 | 2875 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2001 | 3726 | 0.020 |
Why?
|
Myocardial Contraction | 2 | 2006 | 1526 | 0.020 |
Why?
|
Radiography | 1 | 2021 | 6991 | 0.020 |
Why?
|
Body Mass Index | 2 | 2024 | 13055 | 0.020 |
Why?
|
Reference Standards | 1 | 2013 | 1014 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2016 | 1434 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2008 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4148 | 0.020 |
Why?
|
Chelating Agents | 2 | 1961 | 385 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3580 | 0.020 |
Why?
|
Granulocytes | 1 | 1990 | 551 | 0.020 |
Why?
|
Pain | 1 | 2023 | 5100 | 0.020 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 2008 | 184 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3904 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 22296 | 0.020 |
Why?
|
Program Development | 1 | 2013 | 1300 | 0.020 |
Why?
|
Risk | 2 | 2012 | 9621 | 0.020 |
Why?
|
Brain | 2 | 2006 | 27453 | 0.020 |
Why?
|
Electrophoresis, Paper | 1 | 1965 | 14 | 0.020 |
Why?
|
Proteus | 1 | 1965 | 11 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8513 | 0.020 |
Why?
|
Achromobacter | 1 | 1965 | 8 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18435 | 0.020 |
Why?
|
Cytokines | 1 | 2001 | 7453 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5892 | 0.020 |
Why?
|
Ornithine | 1 | 1965 | 79 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6320 | 0.020 |
Why?
|
Cause of Death | 1 | 2016 | 3721 | 0.020 |
Why?
|
Electrophoresis | 1 | 1965 | 226 | 0.020 |
Why?
|
Cathepsins | 2 | 1977 | 242 | 0.020 |
Why?
|
Carboxy-Lyases | 1 | 1965 | 85 | 0.020 |
Why?
|
Pseudomonas | 1 | 1965 | 124 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 26395 | 0.020 |
Why?
|
Chickens | 3 | 1977 | 845 | 0.010 |
Why?
|
Treatment Outcome | 3 | 2018 | 65480 | 0.010 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.010 |
Why?
|
Histidine | 1 | 1965 | 302 | 0.010 |
Why?
|
Glutamates | 1 | 1965 | 385 | 0.010 |
Why?
|
Enterobacteriaceae | 1 | 1965 | 161 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4339 | 0.010 |
Why?
|
Phenylalanine | 1 | 1965 | 368 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2763 | 0.010 |
Why?
|
Comorbidity | 1 | 2018 | 10592 | 0.010 |
Why?
|
False Negative Reactions | 1 | 2004 | 575 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10765 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2932 | 0.010 |
Why?
|
Tissue Donors | 1 | 2013 | 2382 | 0.010 |
Why?
|
Tryptophan | 1 | 1965 | 482 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3860 | 0.010 |
Why?
|
Myocardium | 2 | 2008 | 4790 | 0.010 |
Why?
|
Aspartic Acid | 1 | 1965 | 577 | 0.010 |
Why?
|
Stroke Volume | 2 | 2007 | 5622 | 0.010 |
Why?
|
Physicians | 1 | 2021 | 4607 | 0.010 |
Why?
|
Research Design | 1 | 2018 | 6214 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2483 | 0.010 |
Why?
|
Heart Failure | 1 | 2006 | 11879 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2004 | 963 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1963 | 412 | 0.010 |
Why?
|
Arginine | 1 | 1965 | 932 | 0.010 |
Why?
|
Ciguatera Poisoning | 1 | 1961 | 1 | 0.010 |
Why?
|
Plaque, Amyloid | 1 | 2006 | 769 | 0.010 |
Why?
|
Serine | 1 | 1965 | 831 | 0.010 |
Why?
|
Fish Venoms | 1 | 1961 | 3 | 0.010 |
Why?
|
Aspartate Aminotransferases | 1 | 1963 | 414 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2006 | 750 | 0.010 |
Why?
|
Brucella | 1 | 1961 | 10 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 1963 | 246 | 0.010 |
Why?
|
Tyrosine | 1 | 1965 | 1427 | 0.010 |
Why?
|
Foodborne Diseases | 1 | 1961 | 41 | 0.010 |
Why?
|
Microspheres | 1 | 2004 | 789 | 0.010 |
Why?
|
Oxidoreductases | 1 | 1963 | 412 | 0.010 |
Why?
|
Lysine | 1 | 1965 | 1000 | 0.010 |
Why?
|
Oxyquinoline | 1 | 1960 | 17 | 0.010 |
Why?
|
Family Health | 1 | 2005 | 1255 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 8094 | 0.010 |
Why?
|
Tetracyclines | 1 | 1960 | 64 | 0.010 |
Why?
|
Citrates | 1 | 1960 | 134 | 0.010 |
Why?
|
Citric Acid | 1 | 1960 | 124 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11116 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1998 | 0.010 |
Why?
|
Histamine | 1 | 1961 | 496 | 0.010 |
Why?
|
Amino Acids | 1 | 1965 | 1716 | 0.010 |
Why?
|
Models, Statistical | 1 | 2013 | 5110 | 0.010 |
Why?
|
Anti-Bacterial Agents | 4 | 1962 | 7478 | 0.010 |
Why?
|
Astrocytes | 1 | 2006 | 1349 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13510 | 0.010 |
Why?
|
Fishes | 1 | 1961 | 606 | 0.010 |
Why?
|
Triglycerides | 1 | 2005 | 2464 | 0.010 |
Why?
|
Microglia | 1 | 2006 | 1376 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14794 | 0.010 |
Why?
|
Administration, Oral | 1 | 2005 | 4040 | 0.010 |
Why?
|
Geriatric Assessment | 1 | 2004 | 1422 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30265 | 0.010 |
Why?
|
Pepstatins | 1 | 1976 | 10 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 1976 | 141 | 0.010 |
Why?
|
Mitral Valve | 1 | 2004 | 1475 | 0.010 |
Why?
|
Survival Analysis | 1 | 2008 | 10115 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 1976 | 527 | 0.010 |
Why?
|
DDT | 1 | 1974 | 32 | 0.010 |
Why?
|
Thymidine | 1 | 1994 | 297 | 0.010 |
Why?
|
Respiratory Burst | 1 | 1994 | 110 | 0.010 |
Why?
|
Bacteria | 1 | 1965 | 2216 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 60131 | 0.010 |
Why?
|
Swine | 1 | 2004 | 5997 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1994 | 826 | 0.010 |
Why?
|
Escherichia coli | 1 | 1965 | 4213 | 0.010 |
Why?
|
Rabbits | 2 | 1977 | 4774 | 0.010 |
Why?
|
Length of Stay | 1 | 2006 | 6526 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 89244 | 0.010 |
Why?
|
Immunity | 1 | 1977 | 1003 | 0.010 |
Why?
|
Antigens | 1 | 1974 | 1444 | 0.000 |
Why?
|
Cell Division | 1 | 1994 | 4478 | 0.000 |
Why?
|
Tumor Cells, Cultured | 1 | 1994 | 6131 | 0.000 |
Why?
|
Chlortetracycline | 1 | 1962 | 5 | 0.000 |
Why?
|
Oxytetracycline | 1 | 1962 | 11 | 0.000 |
Why?
|
Staphylococcus | 1 | 1962 | 146 | 0.000 |
Why?
|
Virulence | 1 | 1963 | 1298 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1977 | 68 | 0.000 |
Why?
|
Hemagglutination Tests | 1 | 1977 | 76 | 0.000 |
Why?
|
Hemagglutination | 1 | 1974 | 32 | 0.000 |
Why?
|
Immunoglobulin G | 2 | 1977 | 4568 | 0.000 |
Why?
|
Sheep | 1 | 1974 | 1451 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1974 | 1528 | 0.000 |
Why?
|
Macrophages | 1 | 1977 | 5801 | 0.000 |
Why?
|